[Influenza and pneumococcal vaccination in adults].
Identifieur interne : 000310 ( Ncbi/Curation ); précédent : 000309; suivant : 000311[Influenza and pneumococcal vaccination in adults].
Auteurs : T. Weinke [Allemagne] ; W. GüthoffSource :
- Deutsche medizinische Wochenschrift (1946) [ 1439-4413 ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Allemagne, Bactériémie (), Bactériémie (immunologie), Bactériémie (épidémiologie), Grippe humaine (immunologie), Grippe humaine (mortalité), Grippe humaine (épidémiologie), Humains, Production d'anticorps, Relations médecin-patient, Saisons, Sujet âgé, Vaccins antigrippaux (administration et posologie), Vaccins antipneumococciques (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux, Vaccins antipneumococciques.
- immunologie : Bactériémie, Grippe humaine.
- mortalité : Grippe humaine.
- épidémiologie : Bactériémie, Grippe humaine.
- Adulte, Adulte d'âge moyen, Allemagne, Bactériémie, Humains, Production d'anticorps, Relations médecin-patient, Saisons, Sujet âgé.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adult, Aged, Antibody Formation, Bacteremia (epidemiology), Bacteremia (immunology), Bacteremia (prevention & control), Germany, Humans, Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (mortality), Middle Aged, Physician-Patient Relations, Pneumococcal Vaccines (administration & dosage), Seasons.
- MESH :
- chemical , administration & dosage : Influenza Vaccines, Pneumococcal Vaccines.
- geographic : Germany.
- epidemiology : Bacteremia, Influenza, Human.
- immunology : Bacteremia, Influenza, Human.
- mortality : Influenza, Human.
- prevention & control : Bacteremia.
- Adult, Aged, Antibody Formation, Humans, Middle Aged, Physician-Patient Relations, Seasons.
Abstract
Seasonal influenza causes yearly increased morbidity and mortality especially in older adults and patients with a comorbidity. Vaccination coverage in Germany reaches 60 % in the age group of persons over 60 years, but fails to reach the WHO target of 75 %. Improved immunogenicity of vaccines is necessary because of the occurrence of immunosenescence. This can be achieved by improved adjuvants or by new routes of application like the intradermal vaccination which produces higher antibody levels. Invasive pneumococcal infections cause up to 10000 deaths in Germany every year. The polysaccharide vaccine prevents 60 - 80 % of invasive bacteremic pneumococcal infections and reduces the mortality and severity of invasive courses. Only 20 % of the target group is vaccinated: German physicians should stress the need for pneumococcal vaccination.
DOI: 10.1055/s-0029-1220215
PubMed: 19353477
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000748
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000745
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000704
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000310
Links to Exploration step
pubmed:19353477Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Influenza and pneumococcal vaccination in adults].</title><author><name sortKey="Weinke, T" sort="Weinke, T" uniqKey="Weinke T" first="T" last="Weinke">T. Weinke</name><affiliation wicri:level="1"><nlm:affiliation>Zentrum für Innere Medizin, Klinikum Ernst von Bergmann, Potsdam. tweinke@klinikumevb.de</nlm:affiliation><country wicri:rule="url">Allemagne</country></affiliation></author><author><name sortKey="Guthoff, W" sort="Guthoff, W" uniqKey="Guthoff W" first="W" last="Güthoff">W. Güthoff</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19353477</idno><idno type="pmid">19353477</idno><idno type="doi">10.1055/s-0029-1220215</idno><idno type="wicri:Area/PubMed/Corpus">000748</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000748</idno><idno type="wicri:Area/PubMed/Curation">000745</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000745</idno><idno type="wicri:Area/PubMed/Checkpoint">000704</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000704</idno><idno type="wicri:Area/Ncbi/Merge">000310</idno><idno type="wicri:Area/Ncbi/Curation">000310</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Influenza and pneumococcal vaccination in adults].</title><author><name sortKey="Weinke, T" sort="Weinke, T" uniqKey="Weinke T" first="T" last="Weinke">T. Weinke</name><affiliation wicri:level="1"><nlm:affiliation>Zentrum für Innere Medizin, Klinikum Ernst von Bergmann, Potsdam. tweinke@klinikumevb.de</nlm:affiliation><country wicri:rule="url">Allemagne</country></affiliation></author><author><name sortKey="Guthoff, W" sort="Guthoff, W" uniqKey="Guthoff W" first="W" last="Güthoff">W. Güthoff</name></author></analytic><series><title level="j">Deutsche medizinische Wochenschrift (1946)</title><idno type="eISSN">1439-4413</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antibody Formation</term><term>Bacteremia (epidemiology)</term><term>Bacteremia (immunology)</term><term>Bacteremia (prevention & control)</term><term>Germany</term><term>Humans</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (mortality)</term><term>Middle Aged</term><term>Physician-Patient Relations</term><term>Pneumococcal Vaccines (administration & dosage)</term><term>Seasons</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allemagne</term><term>Bactériémie ()</term><term>Bactériémie (immunologie)</term><term>Bactériémie (épidémiologie)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (mortalité)</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Production d'anticorps</term><term>Relations médecin-patient</term><term>Saisons</term><term>Sujet âgé</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antipneumococciques (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Bacteremia</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Bactériémie</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Bacteremia</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Bacteremia</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Bactériémie</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antibody Formation</term><term>Humans</term><term>Middle Aged</term><term>Physician-Patient Relations</term><term>Seasons</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allemagne</term><term>Bactériémie</term><term>Humains</term><term>Production d'anticorps</term><term>Relations médecin-patient</term><term>Saisons</term><term>Sujet âgé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Seasonal influenza causes yearly increased morbidity and mortality especially in older adults and patients with a comorbidity. Vaccination coverage in Germany reaches 60 % in the age group of persons over 60 years, but fails to reach the WHO target of 75 %. Improved immunogenicity of vaccines is necessary because of the occurrence of immunosenescence. This can be achieved by improved adjuvants or by new routes of application like the intradermal vaccination which produces higher antibody levels. Invasive pneumococcal infections cause up to 10000 deaths in Germany every year. The polysaccharide vaccine prevents 60 - 80 % of invasive bacteremic pneumococcal infections and reduces the mortality and severity of invasive courses. Only 20 % of the target group is vaccinated: German physicians should stress the need for pneumococcal vaccination.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000310 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000310 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:19353477
|texte= [Influenza and pneumococcal vaccination in adults].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:19353477" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |